Alivus Life Sciences (BOM:543322) Days Sales Outstanding : 136.23 (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Alivus Life Sciences Days Sales Outstanding?

Alivus Life Sciences's average Accounts Receivable for the three months ended in Mar. 2025 was ₹9,697 Mil. Alivus Life Sciences's Revenue for the three months ended in Mar. 2025 was ₹6,495 Mil. Hence, Alivus Life Sciences's Days Sales Outstanding for the three months ended in Mar. 2025 was 136.23.

The historical rank and industry rank for Alivus Life Sciences's Days Sales Outstanding or its related term are showing as below:

BOM:543322' s Days Sales Outstanding Range Over the Past 10 Years
Min: 113.04 Med: 125.67 Max: 132.72
Current: 127.96

During the past 7 years, Alivus Life Sciences's highest Days Sales Outstanding was 132.72. The lowest was 113.04. And the median was 125.67.

BOM:543322's Days Sales Outstanding is ranked worse than
83.07% of 957 companies
in the Drug Manufacturers industry
Industry Median: 72.09 vs BOM:543322: 127.96

Alivus Life Sciences's Days Sales Outstanding increased from Mar. 2024 (130.16) to Mar. 2025 (136.23).

Alivus Life Sciences Days Sales Outstanding Historical Data

The historical data trend for Alivus Life Sciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alivus Life Sciences Days Sales Outstanding Chart

Alivus Life Sciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Days Sales Outstanding

Get a 7-Day Free Trial

123.35

113.04

131.92

125.67

132.67

Alivus Life Sciences Quarterly Data
	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															130.16	118.66	139.54	110.20	136.23

Competitive Comparison of Alivus Life Sciences's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Alivus Life Sciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alivus Life Sciences's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alivus Life Sciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Alivus Life Sciences's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Alivus Life Sciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Alivus Life Sciences's Days Sales Outstanding for the fiscal year that ended in Mar. 2025 is calculated as

	Days Sales Outstanding (A: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (7654.32	+	9697.41)	/	2 )	/	23868.84	*	365
=	8675.865					/	23868.84	*	365
=	132.67

Alivus Life Sciences's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (0	+	9697.41)	/	1 )	/	6495.45	*	365 / 4
=	9697.41					/	6495.45	*	365 / 4
=	136.23

Alivus Life Sciences (BOM:543322) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Alivus Life Sciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Alivus Life Sciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Alivus Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alivus Life Sciences Ltd (BOM:543322) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

ALIVUS:India

Address

470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099

Website

https://www.alivus.com

Alivus Life Sciences Ltd, formerly Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Alivus Life Sciences Headlines

No Headlines